Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps

Clicks: 270
ID: 112861
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Caps for spending on specialty drugs were associated with substantial reductions in spending on specialty drugs among patients with the highest out-of-pocket costs, without detectable increases in health-plan spending, a proxy for future insurance premiums. (Funded by the Robert Wood Johnson Foundat …
Reference Key
k2020thepatient Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yeung K;Barthold D;Dusetzina SB;Basu A;;
Journal The New England journal of medicine
Year 2020
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/32757524
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Insurance humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult middle aged Comparative Study United States pmid:32757524 doi:10.1056/nejmsa1910366 kai yeung douglas barthold anirban basu chronic disease / drug therapy* chronic disease / economics cost sharing / economics cost sharing / legislation & jurisprudence* delaware drug costs / legislation & jurisprudence* health expenditures / statistics & numerical data* pharmaceutical services / economics* pharmaceutical services / legislation & jurisprudence louisiana maryland prescription fees / legislation & jurisprudence state government*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.